Tech Company Financing Transactions
Allegria Therapeutics Funding Round
Forty51 Ventures and HighLight Capital participated in a $5.1 million Seed capital raise for Allegria Therapeutics. The funding round was announced on 12/11/2025.
Transaction Overview
Company Name
Announced On
12/11/2025
Transaction Type
Venture Equity
Amount
$5,100,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to progress its lead program towards pre-clinical candidates in support of nomination its first clinical candidate, while at the same time meaningfully advancing its discovery-stage programs.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Aeschenvorstadt 48
Basel, 4051
Switzerland
Basel, 4051
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Allegria Therapeutics, a Basel, Switzerland-based company focused on advancing a pipeline of therapeutics for mast cell-mediated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria van Dongen
Browse more venture capital transactions:
Prev: 12/11/2025: Skydo venture capital transaction
Next: 12/11/2025: K2 Space venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs